Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Artrya Limited ( (AU:AYA) ) just unveiled an announcement.
Artrya Limited has announced the issuance of 200,000 new ordinary fully paid securities, which are set to be quoted on the ASX under the code AYA on September 26, 2025. This move is part of the company’s strategic efforts to enhance its financial position and support its ongoing growth initiatives in the healthcare technology sector, potentially impacting its market presence and stakeholder interests positively.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare technology industry, focusing on developing innovative solutions for the diagnosis and management of coronary artery disease. The company leverages advanced imaging and artificial intelligence to enhance the detection and treatment of heart conditions, aiming to improve patient outcomes and streamline healthcare processes.
Average Trading Volume: 627,889
Technical Sentiment Signal: Buy
Current Market Cap: A$325.2M
Learn more about AYA stock on TipRanks’ Stock Analysis page.